Results 61 to 70 of about 156,017 (326)

Patients’ experiences treated with open-label placebo versus double-blind placebo: a mixed methods qualitative study [PDF]

BMC Psychology, 2022
Abstract Background There is increasing evidence suggesting that open-label placebo (OLP) is an effective treatment for several medical conditions defined by self-report. However, little is known about patients’ experiences with OLP, and no studies have directly compared patients’ experiences in double-blind placebo (DBP)
Haas, Julia W., Ongaro, Giulio, Jacobson, Eric, Conboy, Lisa A., Nee, Judy, Iturrino, Johanna, Rangan, Vikram, Lembo, Anthony, Kaptchuk, Ted J., Ballou, Sarah   +9 more
openaire   +5 more sources

If only they knew! A non‐inferiority randomized controlled trial comparing deceptive and open‐label placebo in healthy individuals

European Journal of Pain, 2023
Placebo use is widespread in clinical practice. However, they are most often administered deceptively rather than openly. It is often suggested that open‐label placebos (OLP) are less effective than deceptive placebos (DP).
L. Druart, S. Graham Longsworth, H. Terrisse, C. Locher, C. Blease, C. Rolland, N. Pinsault   +6 more
semanticscholar   +1 more source

Psychological determinants of whole-body endurance performance [PDF]

, 2015
Background: No literature reviews have systematically identified and evaluated research on the psychological determinants of endurance performance, and sport psychology performance-enhancement guidelines for endurance sports are not founded on a ...
A Bandura, A Hatzigeorgiadis, A Kühberger, A Miller, A Renfree, AE Bauman, Alister McCormick, AW Blanchfield, B Donohue, B Donohue, B Pageaux, BD Franks, BH Thomas, BPC Smirmaul, BS Rushall, BW Brewer, C MacMahon, Carla Meijen, CD Stevinson, CI Karageorghis, CI Karageorghis, CJ Beedie, CRD Wagstaff, D Bath, DB Hollander, DE Saintsing, DT Campbell, E Lind, G Tenenbaum, G Tenenbaum, GL Martin, HS Hodgins, HS Jones, J Baker, J Barker, J Cohen, J Corbett, J Dosil, J Simons, J Stoeber, J Taylor, J Taylor, JA Jackson, JH Wilmore, JH Wilmore, JJ Martin, JL Andreacci, JL Kress, JW Brehm, KS Masters, LB Kyllo, LF Chitwood, LM Scott, M Bérdi, M Hojat, M Houston, M Hulleman, M Kellmann, M Miller, M Muraven, M Petticrew, M Sheard, M Viru, MJ Barwood, MJ Barwood, MP Buman, N Brick, NL Holt, P Lindsay, P Post, P Salmon, PB Gastin, PM Beeson, R Desharnais, R Weinberg, RA Hamilton, RA Wright, RC Thelwell, RC Thelwell, RJ Moffatt, RM Ryan, RS Burhans, RS Weinberg, S Marcora, S Marcora, S Michie, S Tuffey, Samuele Marcora, SB Morris, SJ Caird, SL Halson, SL Higgs, SM Marcora, SM Marcora, TD Noakes, TD Patrick, TE Scruggs, TM Okwumabua, VR Clark, W Borg, WJ Bubb, WJ Rejeski, WP Morgan, WP Morgan, WR Boot, WW Peveler, Y Theodorakis   +106 more
core   +4 more sources

Noninvasive vagus nerve stimulation as acute therapy for migraine. The randomized PRESTO study [PDF]

, 2018
Objective: To evaluate the efficacy, safety, and tolerability of noninvasive vagus nerve stimulation (nVNS; gammaCore; electroCore, LLC, Basking Ridge, NJ) for the acute treatment of migraine in a multicenter, double-blind, randomized, sham-controlled ...
Ambrosini, Anna, Barbanti, Piero, De Tommaso, Marina, Dorlas, Stefanie, Geppetti, Pierangelo, Grazzi, Licia, Liebler, Eric, Martelletti, Paolo, Negro, Andrea, Pierangeli, Giulia, Rainero, Innocenzo, Sarchielli, Paola, Tassorelli, Cristina   +12 more
core   +2 more sources

Effect of Open-label Placebo on Children and Adolescents With Functional Abdominal Pain or Irritable Bowel Syndrome: A Randomized Clinical Trial.

JAMA pediatrics, 2022
Importance Although it is widely believed that concealment or deception is required to elicit a placebo response, recent studies with adults suggest that open-label placebo (OLP) (ie, honestly prescribed placebos) can yield significant benefits.
S. Nurko, M. Saps, Joe Kossovsky, S. Zion, C. Di Lorenzo, Karla K. Vaz, Kelsey Hawthorne, Rina Wu, Steven L Ciciora, J. Rosen, T. Kaptchuk, J. Kelley   +11 more
semanticscholar   +1 more source

Placebos in primary care? a nominal group study explicating UK GP and patient views of six theoretically plausible models of placebo practice

BMJ Open, 2020
ObjectivesTo better understand which theoretically plausible placebogenic techniques might be acceptable in UK primary care.DesignA qualitative study using nominal group technique and thematic analysis.
Adam W A Geraghty, Mohana Ratnapalan, Beverly Coghlan, Mengxin Tan, Hazel Everitt, George Lewith, Felicity L Bishop   +6 more
doaj   +1 more source

Do antidepressants cure or create abnormal brain states? [PDF]

, 2006
Moncrieff and Cohen argue that psychotropic drugs create abnormal states that may co-incidentally relieve symptoms of mental ...
Beasley, Beasley, Bourin, Breggin, Cohen, David Cohen, Delgado, Deptula, Dewa, Drevets, Dumont, Emrich, Fisher, Furlan, Goldberg, Harmer, Harmer, Herrmann, Hyman, Imlah, Joanna Moncrieff, Kennedy, Kirsch, Knegtering, Lacasse, Leo, Lowther, Malhi, Matsubara, Mayers, Meyer, Moncrieff, Moncrieff, Moncrieff, Moncrieff, Murphy, Niklson, Parsey, Patten, Pilgrim, Ramaekers, Ramaekers, Raptopoulos, Reivich, Rickels, Robbe, Robertson, Robinson, Rush, Sargent, Schildkraut, Stockmeier, Tranter, Tuma, Van Putten, Wingen   +55 more
core   +3 more sources

Effects of an open-label placebo intervention on reactions to social exclusion in healthy adults: a randomized controlled trial

Scientific Reports, 2023
Social exclusion, that is being left out by others, can have adverse consequences for individuals’ psychological well-being. Even short-term experiences of social exclusion strongly threaten basic psychological needs and cause so-called social pain ...
Leonie Stumpp, Melissa Jauch, Dilan Sezer, Jens Gaab, Rainer Greifeneder   +4 more
doaj   +1 more source

‘Placebos’ and the logic of placebo comparison [PDF]

, 2012
Robin Nunn has argued that we should stop using the terms ‘placebo’ and ‘placebo effect’. I argue in support of Nunn’s position by considering the logic of why we perform placebo comparisons.
Turner, Andrew
core   +2 more sources

Treatments for spasticity and pain in multiple sclerosis: a systematic review [PDF]

, 2003
Objectives: To identify the drug treatments currently available for the management of spasticity and pain in multiple sclerosis (MS), and to evaluate their clinical and cost-effectiveness.
Beard, S.M., Hunn, A., Wight, J.
core   +1 more source